Monthly Archives: May 2023

Health

New York’s Mount Sinai Health System Opens Concierge Medicine Practice in West Palm Beach

Leave a comment


“The new Concierge Care Practice in West Palm Beach will provide comprehensive, personalized care for patients with the goal of keeping patients well and out of the hospital,” – Alicia Gresham, Senior Vice President and Chief Operating Officer of Network Practices at the Mount Sinai Health System


NEW YORK (PRWEB)

Mount Sinai Health System in New York, as part of its drive to bring high-quality, innovative, and dedicated care to patients in the southeast Florida area, is opening a personalized concierge care facility at 360 Rosemary in West Palm Beach, Florida.

Mount Sinai New York-Concierge Care is the third Mount Sinai facility in Florida offering access to innovative, research-driven expertise from one of New York City’s largest academic health systems. The two other Palm Beach County locations are Mount Sinai Doctors New York-Palm Beach, launched in 2018, and Mount Sinai Heart New York-Palm Beach, launched in 2015.

“With the opening of the newest Mount Sinai Health System Concierge Care facility in downtown West Palm Beach, our Health System continues to expand and to find a way to bring the best patient-centered care to Florida,” said Kenneth L. Davis, Chief Executive Officer of the Mount Sinai Health System. “Patients have choices and expect high-level medical care and access to our top-ranked specialists in New York, and this practice will meet the needs of a very savvy patient population.”

Mount Sinai New York-Concierge Care will offer two membership options—premier and premier plus—with services including 24/7 access to physicians, home visits, extended visits, telehealth appointments, cardiac assessments, annual full-body skin exams, nutrition counseling, screenings, and more. This facility will be located on the ground level of the 360 Rosemary office building at 575 Fern Street in West Palm Beach. The space will consist of 5,850 square feet and 10 exam rooms, a dermatology spa and treatment room for cosmetic procedures and hydrofacials, dermatological laser, X-ray, and ultrasound.

“Convenient access to outstanding health care is an essential component of all great neighborhoods,” said Gopal Rajegowda, Partner at Related Southeast. “Related is proud to welcome Mount Sinai New York, expanding health care offerings for those who live and work in the community, and further supporting the evolution of healthy lifestyle and longevity in downtown West Palm Beach.”

“The new Concierge Care Practice in West Palm Beach will provide comprehensive, personalized care for patients with the goal of keeping patients well and out of the hospital,” said Alicia Gresham, Senior Vice President and Chief Operating Officer of Network Practices at the Mount Sinai Health System. “As we continue to see more older adults and a growing younger demographic moving to the area who want a healthy lifestyle and longevity, we have included services to optimize health and wellness including annual cardiology assessments, pulmonary care and testing, annual skin exams, and more.”

Patients of Mount Sinai New York-Concierge Care will have access to leading Mount Sinai experts in concierge medicine, dermatology, nutrition, and cardiology to receive state-of-the-art treatment options, consultations, and personalized visits. Immediate access to specialists will be offered along with expedited access to Mount Sinai specialists in New York and a network of specialists in Palm Beach County, should patients need. Patients will also have access to a dedicated clinical team and patient navigators to coordinate care in the office, at home, or at a local hospital, as well as local events where patients can listen to Mount Sinai physicians speak on trending topics in health and wellness.

About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report’s Best Hospitals, receiving high “Honor Roll” status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children’s Hospital among the country’s best in several pediatric specialties. For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email:

Health

Predicting Immune Checkpoint Inhibitor Response Directly from Tumor RNA-Sequencing Data, Upcoming Webinar Hosted by Xtalks

Leave a comment


There is an urgent need for robust predictive biomarkers for immune checkpoint inhibitor response to select patients with likely clinical benefit from this costly treatment.


TORONTO (PRWEB)

Immune checkpoint inhibitors (ICI) have become the standard of care as a first- or second-line systemic treatment for patients with various cancer types. Unfortunately, many patients do not respond to this treatment and the occurrence of immune-related adverse events varies widely. There is an urgent need for robust predictive biomarkers for immune checkpoint inhibitor response to select patients with likely clinical benefit from this costly treatment.

Several biomarkers, aimed at predicting response to immune checkpoint inhibitors, have been proposed, including PD-L1 expression, tumor mutation burden (TMB), infiltration of cytotoxic T-cells in the tumor, Microsatellite Instability (MSI) and expression of various immune gene signatures. However, these individual biomarkers have suboptimal performance and multiple complementary omics technologies are required to properly quantify them. Integration of these multi-omic biomarkers has proven valuable in increasing the accuracy and robustness of immune checkpoint inhibitor response prediction.

The featured speakers have developed a computational pipeline that determines the expressed mutation burden (eTMB), MSI status, fraction of infiltrating immune cells and various immune gene expression signatures directly from the RNA-sequencing profile of the tumor. Each biomarker is quantified using a dedicated algorithm that applies machine learning (eTMB and MSI) or computational deconvolution (infiltrating immune cells) and integrates external data sources to maximize performance. Algorithm performance has been validated on large cohorts of tumor RNA-sequencing data with matching gold standard quantification of said biomarkers. Moreover, integrating these biomarkers improves prediction of response to checkpoint inhibition therapy.

Register for this webinar to learn how this computational approach enables the quantification of various immune checkpoint inhibitor response biomarkers from a single omics layer (RNA-seq) and improves response prediction.

Join Pieter Mestdagh, Computational Biology Manager, CellCarta, for the live webinar on Wednesday, May 31, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Predicting Immune Checkpoint Inhibitor Response Directly from Tumor RNA-Sequencing Data.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Society: Christianity

empty tomb®’s Mission Match® Revised Focus Builds on Work Begun in 2002

Leave a comment


Mission Match’s focus on under-age-five child survival builds on more general mission work done by churches from 2002 through 2016 with matching contributions.


CHAMPAIGN, Ill. (PRWEB)

empty tomb, inc.’s Mission Match’s focus is now on churches helping, in Jesus’ name, to meet the goals to reduce the rate of under-age-five child deaths in 40 countries.

These 40 countries, as of 2015, were behind the curve in meeting goals set by world leaders to reduce the rate of child deaths.

A church in the U.S. can apply for a matching contribution from $500 to $3,000 in $500 increments.

The church mission projects can, for example, support medical workers, provide a specific item needed at a medical facility, or furnish supplies that contribute to child survival. It is understood that other age groups might also be assisted by the projects.

Mission Match is seeking 30 churches to launch a next phase in developing this mission incentive tool. Churches can apply for matching contributions for their medical mission projects.

Mission Match’s focus on under-age-five child survival builds on more general mission work done by churches from 2002 through 2016 with matching contributions.

From 2002 to 2016, churches could apply for Mission Match matching contributions for any type of mission project the congregation chose. A total of 86 churches from 23 states carried out 112 projects during those years. Mission Match provided $222,000 that was matched by a reported $335,115 raised in the congregations for their projects.

In this next phase, at least 30 congregations can receive matching contributions for their new or expanded medical missions projects to benefit child survival in any one of 40 countries.

The list of 40 countries included in the Mission Match focus is available at missionmatch.org on the 40 Countries page.

Churches can find information about applying for a Mission Match matching contribution at missionmatch.org and selecting the Church Application page from the menu.

Share article on social media or email:

Health

Medical Marijuana Treatment Clinics Opens as TruReleaf MD in Jackson, Mississippi

Leave a comment


“This new industry promises to offer us natural alternatives to powerful narcotics, which have caused senseless deaths of too many of our neighbors and their loved ones.” says Dr. Roberts, licensed medical marijuana physician.


JACKSON, Miss. (PRWEB)

Jackson — TruReleaf MD is expanding to Jackson, MS, as one of the state’s first medical marijuana physicians providing relief for patients through medical cannabis certifications with in-person reviews of medical conditions and medical records.

With the passage of Senate Bill 2095, Mississippi’s Medical Marijuana Program was streamlined, providing expanded medical marijuana care to patients. One of the significant provisions allows physicians to recommend medicine to patients if they believe that their patient’s qualifying debilitating medical condition would benefit from medical marijuana or that it would alleviate the symptoms of a qualifying debilitating medical condition.

TruReleaf MD comes to the state with over seven years of experience providing compassionate care in Florida as MMTCFL. Following the legalization of medical marijuana for qualifying conditions, the Medical Marijuana Treatment Clinics of Florida quickly became a pillar in the medical marijuana industry, redefining what it means to be a medical marijuana patient and providing a natural relief option to those seeking care.

With this experience, TruReleaf MD aims to restore patient quality of life through cannabis-based alternative treatments. They believe that relief is fundamental to having control over one’s life and aim to give patients the necessary tools to make the best choice for their own health.

“This new industry promises to offer us natural alternatives to powerful narcotics, which have caused senseless deaths of too many of our neighbors and their loved ones.” says Dr. Roberts, licensed medical marijuana physician. The clinic will allow patients more opportunities to take control of their conditions, putting them one step closer to creating the life they want.

The clinic currently offers in-person appointments for those with qualifying conditions. To book an appointment, patients can visit http://www.getmymississippicard.com to schedule online or call 601-768-7944 to speak with a Patient Care Coordinator to schedule over the phone.

TruReleaf MD’s mission is to support and educate the public regarding safe access and use of medical marijuana in Mississippi. Following state guidelines, TruReleaf MD aims to simplify the process of getting a medical marijuana card and help patients take control of their care.

Share article on social media or email:

Health

Using Machine Learning to Find High Potential Lead Molecules, Upcoming Webinar Hosted by Xtalks

Leave a comment


Using a rapid combinatorial library and microfluidic high-throughput screening technology, it is possible to quickly design, build and screen molecular libraries to discover bioactive molecules (and inactive molecules) with quality dose-response data.


TORONTO (PRWEB)

The promise of machine learning to dramatically reduce timelines in a lengthy drug discovery process is exciting, but it relies on the ability to generate a trusted set of empirical data and the continuous iteration of models.

In this webinar, the featured speakers will demonstrate their iterative and machine learning-driven discovery engine across multiple disease targets to predict novel, active chemical scaffolds and recognize SARs otherwise not identified by public data alone. Using a rapid combinatorial library and microfluidic high-throughput screening technology, it is possible to quickly design, build and screen molecular libraries to discover bioactive molecules (and inactive molecules) with quality dose-response data. This dose-response data allows library-wide SAR characterizations, empowering deep-learning QSAR model predictions and novel lead generation. The result is core starting points and activity-predictive models that expedite decision-making steps during chemical series progression.

The frontier of medicine is often fraught with early discovery decisions based on limited empirical data. While biologics discovery has been accelerated by leveraging nature’s tools for site-selective mutagenesis and rapid maturation or optimization, small molecule discovery is in desperate need of new tools that will similarly allow rapid learning cycles and optimization of clinically relevant drug properties.

In this webinar, the speakers will explore how empirical and computational platforms scout chemical space, generate measures of SAR and map the critical structural patterns to predict activity and guide development. They also explore the molecular space not previously examined and create predictions to streamline optimization toward higher potential lead molecules.

Join this webinar to learn how custom chemistry and machine learning bring medicines to patients faster.

Join experts from 1859, Ghotas Evindar, PhD, SVP Discovery; Andrew MacConnell, PhD, Cofounder and Scientific Fellow; and Hossam Ashtawy, PhD, Director of AI and ML, for the live webinar on Thursday, May 25, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Using Machine Learning to Find High Potential Lead Molecules.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Health

Medical Marijuana Treatment Clinics Opens as TruReleaf MD in D’Iberville, Mississippi

Leave a comment


“This new industry promises to offer us natural alternatives to powerful narcotics, which have caused senseless deaths of too many of our neighbors and their loved ones.” says Dr. Roberts, licensed medical marijuana physician.


D’IBERVILLE, Miss. (PRWEB)

TruReleaf MD is expanding to D’Iberville, MS, as one of the state’s first medical marijuana physicians providing relief for patients through medical cannabis certifications with in-person reviews of medical conditions and medical records.

With the passage of Senate Bill 2095, Mississippi’s Medical Marijuana Program was streamlined, providing expanded medical marijuana care to patients. One of the significant provisions allows physicians to recommend medicine to patients if they believe that their patient’s qualifying debilitating medical condition would benefit from medical marijuana or that it would alleviate the symptoms of a qualifying debilitating medical condition.

TruReleaf MD comes to the state with over seven years of experience providing compassionate care in Florida as MMTCFL. Following the legalization of medical marijuana for qualifying conditions, the Medical Marijuana Treatment Clinics of Florida quickly became a pillar in the medical marijuana industry, redefining what it means to be a medical marijuana patient and providing a natural relief option to those seeking care.

With this experience, TruReleaf MD aims to restore patient quality of life through cannabis-based alternative treatments. They believe that relief is fundamental to having control over one’s life and aim to give patients the necessary tools to make the best choice for their own health.

“This new industry promises to offer us natural alternatives to powerful narcotics, which have caused senseless deaths of too many of our neighbors and their loved ones.” says Dr. Roberts, licensed medical marijuana physician. The clinic will allow patients more opportunities to take control of their conditions, putting them one step closer to creating the life they want.

The clinic currently offers in-person appointments for those with qualifying conditions. To book an appointment, patients can visit http://www.getmymississippicard.com to schedule online or call 601-768-7944 to speak with a Patient Care Coordinator to schedule over the phone.

TruReleaf MD’s mission is to support and educate the public regarding safe access and use of medical marijuana in Mississippi. Following state guidelines, TruReleaf MD aims to simplify the process of getting a medical marijuana card and help patients take control of their care.

Share article on social media or email:

Health

Ideal Option Opens Addiction Medicine Clinic in El Dorado

Leave a comment



EL DORADO, Ark. (PRWEB)

Ideal Option, a national leader in evidence-based outpatient treatment for addiction to fentanyl, heroin, methamphetamine, alcohol and polysubstance, is now welcoming new patients in El Dorado. The new clinic, located at 625 E Main St, will provide primarily buprenorphine-based medication-assisted treatment with an onsite addiction medicine specialist.

While opioid prescribing and heroin use is on the decline, overdose deaths continue to increase in Arkansas, largely due to the prevalence of fentanyl in the illicit drug supply.

According to the Arkansas Take Back Opioid Dashboard, overdose deaths in Union County increased by 50% and narcotic arrests increased by 39% from 2020 to 2021.

Fentanyl is regularly mixed with other illicit drugs to make them more addictive, often without the user knowing. Polysubstance use disorder is therefore now the most common diagnosis at Ideal Option. According to their Annual Patient Outcomes Report for Arkansas, in 2022, over half of all Ideal Option patients tested positive for more than one substance at enrollment, and 24% tested positive for three or more substances.

The report does offer hope, however, by showing how effective medication-assisted treatment is for reducing isolated and polysubstance use. For patients who remained in treatment with Ideal Option during 2022, lab testing shows:

  • 87% less total opioid use

  • 94% less fentanyl use

  • 96% less heroin use

  • 77% less methamphetamine use

  • 90% less cocaine use

The new clinic in El Dorado is Ideal Option’s tenth location in Arkansas and is opening at a time of desperate need for expanded access to evidence-based treatment from experienced providers. Ideal Option has been specializing in addiction medicine using buprenorphine-based medications such as Suboxone® for 11 years and currently operates 90 clinics in 11 states.

“We continue to see a concerning rise in fentanyl use across Arkansas, creating an urgent demand for specialized treatment,” said Aaron Bunch, community outreach coordinator for Ideal Option. “I am excited to get to work in the great community of El Dorado to tackle this worsening crisis.”

The new Ideal Option clinic in El Dorado is open Monday – Thursday, 7:30 a.m. – 6 p.m. and is located at 625 E Main St, El Dorado, AR 71730.

Most forms of insurance are accepted, including Medicare and Medicaid, and patients can typically get started on treatment for fentanyl, heroin, alcohol or other substances within 1-3 business days.

Patients can make an appointment by calling 1.877.522.1275 or visiting http://www.idealoption.com.  

About Ideal Option 

Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped more than 65,000 patients through a network of 90 office-based medication-assisted treatment (MAT) clinics across 11 states. With a mission to serve under-served communities, Ideal Option accepts most forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are also available. 

Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism. 

In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support.

Share article on social media or email:

Health

Medical Marijuana Treatment Clinics Opens as TruReleaf MD in Oxford, Mississippi

Leave a comment



OXFORD, Miss. (PRWEB)

Oxford — TruReleaf MD is expanding to Oxford, MS, as one of the state’s first medical marijuana physicians providing relief for patients through medical cannabis certifications with in-person reviews of medical conditions and medical records.

With the passage of Senate Bill 2095, Mississippi’s Medical Marijuana Program was streamlined, providing expanded medical marijuana care to patients. One of the significant provisions allows physicians to recommend medicine to patients if they believe that their patient’s qualifying debilitating medical condition would benefit from medical marijuana or that it would alleviate the symptoms of a qualifying debilitating medical condition.

TruReleaf MD comes to the state with over seven years of experience providing compassionate care in Florida as MMTCFL. Following the legalization of medical marijuana for qualifying conditions, the Medical Marijuana Treatment Clinics of Florida quickly became a pillar in the medical marijuana industry, redefining what it means to be a medical marijuana patient and providing a natural relief option to those seeking care.

With this experience, TruReleaf MD aims to restore patient quality of life through cannabis-based alternative treatments. They believe that relief is fundamental to having control over one’s life and aim to give patients the necessary tools to make the best choice for their own health.

“This new industry promises to offer us natural alternatives to powerful narcotics, which have caused senseless deaths of too many of our neighbors and their loved ones.” says Dr. Roberts, licensed medical marijuana physician. The clinic will allow patients more opportunities to take control of their conditions, putting them one step closer to creating the life they want.

The clinic currently offers in-person appointments for those with qualifying conditions. To book an appointment, patients can visit http://www.getmymississippicard.com to schedule online or call 601-768-7944 to speak with a Patient Care Coordinator to schedule over the phone.

TruReleaf MD’s mission is to support and educate the public regarding safe access and use of medical marijuana in Mississippi. Following state guidelines, TruReleaf MD aims to simplify the process of getting a medical marijuana card and help patients take control of their care.

Share article on social media or email:

Health

Braasch Oral Surgery in Bedford, NH Announces New Practice and Website

Leave a comment


Braasch Oral Surgery in Bedford, NH

Braasch Oral Surgery in Bedford, NH

We are honored to have the trust of our patients. Our goal is to provide quality care in a friendly and comfortable environment, and we look forward to continuing that tradition with our new practice.


BEDFORD, N.H. (PRWEB)

Braasch Oral Surgery is pleased to announce the grand opening of its state-of-the-art office and new website. Braasch Oral Surgery is a premier oral and maxillofacial surgery practice in Bedford, NH that specializes in oral surgery and dental implants.

The new website, https://www.braaschoms.com, is aesthetically appealing and offers simple navigation that makes it easy to find specific information regarding the practice and the procedures it performs. In addition, the website features online referrals and access to patient forms.

The practice is led by Dr. Daniel Cameron Braasch, a board-certified oral and maxillofacial surgeon with over a decade of experience in both office and hospital settings. Previously at New Hampshire Oral & Maxillofacial Surgery (NHOMS), Dr. Braasch is excited to bring the highest quality of care to Braasch OMS.

“We are honored to have the trust of our patients,” said Dr. Braasch. “Our goal is to provide quality care in a friendly and comfortable environment, and we look forward to continuing that tradition with our new practice.”

Dr. Braasch is joined by a team of dedicated and well-trained surgical assistants committed to providing the highest quality care and customer service. The practice offers a full range of oral surgery procedures, including wisdom teeth removal, dental implants, facial trauma treatment, and more.

Braasch Oral Surgery’s office is equipped with the latest technology and equipment, including a Carestream Kodak Cone Beam 3D Imaging Scanner, Trios 3D Digital Impressions, 3D guided surgery, and more.

The practice is conveniently located at 404 Riverway Place, Building 4, right off of S. River Road in Bedford, New Hampshire. Braasch Oral Surgery offers a range of oral and maxillofacial procedures, including:


  • Dental implants: Dental implants are placed in the jawbone to replace missing or damaged teeth and provide a foundation for replacement teeth.

  • Bone grafting: Dental bone grafting may be necessary to provide a stable foundation for dental implant placement.

  • Wisdom teeth removal: If wisdom teeth don’t have enough room to grow in or are unable to be kept clean, patients may need to have them removed to prevent future oral problems.

  • Biopsies: Oral cancer screenings and biopsies can address any concerns of the skin within the mouth.

  • Facial trauma: Dr. Braasch can treat facial trauma involving facial bones, teeth, gums, and other soft tissues in an office or hospital setting.

  • Extractions: Teeth may need to be removed when other treatments like fillings, crowns, and root canal therapy cannot be completed.

  • PRGF & PRF: Platelet Rich Growth Factors and Platelet Rich Fibrin can minimize healing time and maximize healing potential after bone grafting and soft tissue procedures.

  • Exposure of an impacted tooth: When a tooth is not able to erupt, an exposure can be performed to assist in bringing the tooth into the proper position.

About Braasch Oral Surgery

Braasch Oral Surgery is located at 404 Riverway Place, Building 4 in Bedford, NH 03110. To make an appointment, call 603-657-1984 or visit the practice online at https://www.braaschoms.com/ to request an appointment.

Share article on social media or email:

Society: Christianity

Pastor Shares Her Story of Discovering Her Sexuality and Her Authentic Self

Leave a comment


News Image


PENSACOLA, Fla. (PRWEB)

Growing up under the influence of her family’s religious teaching and beliefs of the Catholic Church, Reverend Lisa R. Kelson spent a large portion of her life succumbing to their patriarchal teachings and ignoring her own inner compass. In her new book, “A Lesbian’s Awakening to Purpose, Self-Love, and God: A Soul’s Journey to Self-Awareness, Identity, and Truth,” she shares her personal journey to spiritual enlightenment and coming to terms with her authentic self.

“It has taken me nearly 60 years to wake up to my true authentic self as a lesbian,” Kelson said. “In my younger days, I had no idea that there was a deeper and higher self, waiting to be discovered. For many years, I lived from my lower aspect, while trying to fit into society’s social rules and norms.”

In “A Lesbian’s Awakening to Purpose, Self-Love, and God,” Kelson uses her personal experience as an example of how readers can break free of their preconceived ideals of who they are expected to be, and instead free their souls to be their true selves. She addresses the harm that can come from religious teachings, and how it can be exclusionary to those the church does not deem “perfect.”

“When one begins breaking down scripture, outside the oppressive lens of patriarchy,” Kelson said, “one can finally understand how scripture is misunderstood in our current age. These writings were written in an oppressive era, and the literal interpretation are not in alignment with deeper truths.”

Kelson doesn’t want readers to rely on anyone else’s truth, instead she wants them to discover their own.

“My hope in sharing my awakening journey,” Kelson said, “is to help those who feel lost and out of sorts with life. This journey is spiritual and not religious. The answers are already within, waiting to be uncovered.”

“A Lesbian’s Awakening to Purpose, Self-Love, and God: A Soul’s Journey to Self-Awareness, Identity, and Truth”

By The Reverend Lisa R. Kelson

ISBN: 9798765234174 (softcover); 9798765234181 (hardcover)

Available at Balboa Press, Amazon and Barnes & Noble

About the author

Reverend Lisa R. Kelson is a native Floridian. After completing her Bachelors of Sport’s Science Education, she enlisted in the Army. She completed her service after returning home from the Gulf War. Upon the completion of her master’s degree in technology education from the University of Georgia, she returned home to Florida. She soon realized that God was calling her to ministry, and she enrolled in Episcopal Divinity School where she completed her Master of Divinity. While this experience prepared her for church ministry, she would soon awaken to a higher spiritual path where she shifted her focus to awakening her higher self. This path led her to understanding deeper truths, that led to her awakening and freeing her soul. To learn more, please visit https://www.reverendlisarkelson.com/.

General Inquiries:            

LAVIDGE – Phoenix                        

Ashley Fletcher

afletcher@lavidge.com

Share article on social media or email: